Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2127-2137

  Zuo, Nan ^a,b   Suzuki, Yusuke ^a   Sugaya, Takeshi ^a,c   Osaki, Ken ^a   Kanaguchi, Yasuhiko ^a   Wang, Lining ^b   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Strategic and Regulatory Affairs Consulting Department   (Japan)

Author keywords

IgA nephropathy; liver type fatty acid binding protein (L FABP); oxidative stress; tubuloglomerular cross talk

Indexed keywords

4 HYDROXYNONENAL; ALBUMIN; CD68 ANTIGEN; FATTY ACID BINDING PROTEIN; HEME OXYGENASE 1; IMMUNOGLOBULIN A; LIVER TYPE FATTY ACID BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE MARROW TRANSPLANTATION; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC TRANSFECTION; GLOMERULOPATHY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN AGGREGATE; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; MACROPHAGE; MESANGIUM CELL; MOUSE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL PROTECTION; UPREGULATION; URINE LEVEL; WILD TYPE;

ALDEHYDES; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINE CCL2; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULONEPHRITIS, IGA; HEME OXYGENASE-1; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES, PROXIMAL; MESODERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959918494     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq687     Document Type: Article

References (48)

1. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 2002; 59: 1096-1116.
2. Antonenkov VD, Sormunen RT, Ohlmeier S et al. Localization of a portion of the liver isoform of fatty-acid-binding protein (L-FABP) to peroxisomes. Biochem J 2006; 394: 475-484. (Pubitemid 43342548)
3. Ek-Von Mentzer BA, Zhang F, Hamilton JA. Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. Implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem 2001; 276: 15575-15580.
4. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acid binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255. (Pubitemid 39297730)
5. Kamijo-Ikemori A, Sugaya T, Obama A et al. Liver type fatty acid binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 2006; 169: 1107-1117. (Pubitemid 351194349)
6. Kamijo-Ikemori A, Sugaya T, Sekizuka A et al. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid binding protein transgenic mice. Nephrol Dial Transplant 2009; 24: 788-800.
7. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-2097. (Pubitemid 41716440)
8. Floege J, Feehaly J. IgA nephropathy: recent developments. J Am Soc Nephrol 2000; 11: 2395-2403.
9. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748. (Pubitemid 35203906)
10. Grande JP, Walker HJ, Holub BJ et al. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int 2000; 57: 1027-1040. (Pubitemid 30434792)
11. Kobori H, Katsurada A, Ozawa Yet al. Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun 2007; 358: 156-163. (Pubitemid 46719097)
12. Ohashi N, Katsurada A, Miyata K et al. Activation of reactive oxygen species and the rennin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2009; 36: 509-515.
13. Ohashi N, Katsurada A, Miyata K et al. Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2009; 36: 750-755.
14. Imai H, Nakamoto Y, Asakura K et al. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1985; 27: 756-761. (Pubitemid 15064635)
15. Suzuki H, Suzuki Y, Yamanaka T et al. Genome-wide scan in a novel IgA nephropathy model Identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol 2005; 16: 1289-1299. (Pubitemid 41716513)
16. Suzuki H, Suzuki Y, Narita I et al. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 2008; 19: 2384-2395.
17. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004; 24: 197-217. (Pubitemid 38685990)
18. van den Wall Bake AW, Daha MR, Evers-Schouten J et al. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA. Am J Kidney Dis 1988; 12: 410-414.
19. Harper SJ, AllenAC, Pringle JH et al. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 1996; 49: 38-42. (Pubitemid 26037051)
20. Suzuki H, Suzuki Y, Aizawa M et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int 2007; 72: 319-327. (Pubitemid 47172373)
21. Parlakpinar H, Acet A, Gul M et al. Protective effects of melatonin on renal failure in pinealectomized rats. Int J Urol 2007; 14: 743-748. (Pubitemid 47206767)
22. Fong JS, Drummond KN. Method for preparation of glomeruli for metabolic studies. J Lab Clin Med 1968; 71: 1034-1039.
23. Hisada Y, Sakurai H, Sugaya T. Cell to cell interaction between mesangial cells and macrophages induces the expression of monocyte chemoattractant protein-1 through nuclear factor-κB activation. Biochem Biophys Res Commun 2000; 269: 309-316. (Pubitemid 30440295)
24. Okada H, Kikuta T, Inoue T et al. Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner. Am J Pathol 2006; 168: 737-747. (Pubitemid 43327726)
25. Yamamoto T, Noiri E, Ono Y et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894-2902. (Pubitemid 350058396)
26. Gómez-Guerrero C, López-Armada MJ, González E et al. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 1994; 153: 5247-5255. (Pubitemid 24983927)
27. Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 1991; 51: 974-978.
28. Ji C, Kozak KR, Marnett LJ. IkappaB kinase, a molecular target for inhibition by hydroxy-2-nonenal. J Biol Chem 2001; 276: 18223-18228.
29. Chan LY, Leung JC, Tsang AWet al. Activation of tubular epithelial cells by mesangial-derived TNF-a: glomerulotubular communication in IgA nephropathy. Kidney Int 2005; 67: 602-612. (Pubitemid 40139851)
30. Frascà GM, Vangelista A, Biagini G et al. Immunological tubulointerstitial deposits in IgA nephropathy. Kidney Int 1982; 22: 184-191. (Pubitemid 12061653)
31. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE et al. Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 1994; 46: 512-519. (Pubitemid 24253061)
32. Mené P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989; 69: 1347-1424. (Pubitemid 19255840)
33. D'Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003; 63: 809-825. (Pubitemid 36315559)
34. Memon RA, Bass NM, Moser AH et al. Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo. Biochim Biophys Acta 1999; 1440: 118-126. (Pubitemid 29406155)
35. Dubé N, Delvin E, Yotov Wet al. Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines. J Cell Biochem 2001; 81: 613-620. (Pubitemid 32417086)
36. Wang G, Gong Y, Anderson J et al. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 2005; 42: 871-879. (Pubitemid 41401125)
37. Chen A, Chen WP, Sheu LF et al. Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 1994; 173: 119-126. (Pubitemid 24249998)
38. Kashem A, Endoh M, Nomoto Y et al. Fcα R expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy. Kidney Int 1994; 45: 868-875.
39. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T et al. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 2004; 66: 1606-1612. (Pubitemid 39298396)
40. Trachtman H, Chan JC, Chan W et al. Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy. Pediatr Res 1996; 40: 620-626. (Pubitemid 26332592)
41. Kuemmerle NB, Krieg RJ Jr, Chan Wet al. Influence of alpha tocopherol over the time course of experimental IgA nephropathy. Pediatr Nephrol 1999; 13: 108-112. (Pubitemid 29206232)
42. Tang S, Leung JC, Tsang AWet al. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria. Kidney Int 2002; 61: 1655-1665. (Pubitemid 34437919)
43. Habibzadegah-Tari P, Byer K, Khan SR. Oxalate induced expression of monocyte chemoattractant protein-1 (MCP-1) in HK-2 cells involves reactive oxygen species. Urol Res 2005; 33: 440-447. (Pubitemid 41778785)
44. Sung FL, Zhu TY, Au-Yeung KK et al. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 2002; 62: 1160-1170.
45. Duan SZ, Usher MG, Mortensen RM et al. PPARs: the vasculature, inflammation and hypertension. Curr Opin Nephrol Hypertens 2009; 18: 128-133.
46. Hostetler HA, Balanarasimha M, Huang H et al. Glucose regulates fatty acid binding protein interaction with lipids and PPAR{alpha}. J Lipid Res 2010; 51(11): 3103-3116.
47. Nakamura T, Sugaya T, Ebihara I et al. Urinary liver-type fatty acidbinding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy. Am J Nephrol 2005; 25: 447-450. (Pubitemid 41433888)
48. Negishi K, Noiri E, Maeda R et al. Renal L-type fatty acid -binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008; 73: 1374-1384 (Pubitemid 351770480)